Related references
Note: Only part of the references are listed.The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination
Sabrina J. Ritch et al.
FRONTIERS IN ENDOCRINOLOGY (2022)
The PDGF Family Is Associated with Activated Tumor Stroma and Poor Prognosis in Ovarian Cancer
Jiajia Li et al.
DISEASE MARKERS (2022)
Relationship between ascites volume and clinical outcomes in epithelial ovarian cancer
Quan Quan et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2021)
Receptor tyrosine kinases and cancer: oncogenic mechanisms and therapeutic approaches
Punit Saraon et al.
ONCOGENE (2021)
Malignant Ascites in Ovarian Cancer: Cellular, Acellular, and Biophysical Determinants of Molecular Characteristics and Therapy Response
Brittany P. Rickard et al.
CANCERS (2021)
The omentum, a niche for premetastatic ovarian cancer
Xiaojing Ma
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The untapped potential of ascites in ovarian cancer research and treatment
Caroline Elizabeth Ford et al.
BRITISH JOURNAL OF CANCER (2020)
A Novel Role for NUAK1 in Promoting Ovarian Cancer Metastasis through Regulation of Fibronectin Production in Spheroids
Jamie Lee Fritz et al.
CANCERS (2020)
Carcinoma-Associated Mesenchymal Stem Cells Promote Chemoresistance in Ovarian Cancer Stem Cells via PDGF Signaling
Shreya Raghavan et al.
CANCERS (2020)
High-Grade Serous Ovarian Cancer: Basic Sciences, Clinical and Therapeutic Standpoints
Michael-Antony Lisio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Therapeutic Targeting of Collective Invasion in Ovarian Cancer
Laura Moffitt et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Heterotypic CAF-tumor spheroids promote early peritoneal metastatis of ovarian cancer
Qinglei Gao et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Malignant ascites occurs most often in patients with high-grade serous papillary ovarian cancer at initial diagnosis: a retrospective analysis of 191 women treated at Bayreuth Hospital, 2006-2015
Jens Krugmann et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2019)
Transcriptome Profiling Reveals Matrisome Alteration as a Key Feature of Ovarian Cancer Progression
Sumegha Mitra et al.
CANCERS (2019)
Multicellular detachment generates metastatic spheroids during intra-abdominal dissemination in epithelial ovarian cancer
Sara Al Habyan et al.
ONCOGENE (2018)
Massive mining of publicly available RNA-seq data from human and mouse
Alexander Lachmann et al.
NATURE COMMUNICATIONS (2018)
CBX2 identified as driver of anoikis escape and dissemination in high grade serous ovarian cancer
Lindsay J. Wheeler et al.
ONCOGENESIS (2018)
Molecular Mechanisms Regulating Organ-Specific Metastases in Epithelial Ovarian Carcinoma
Maria V. Barbolina
CANCERS (2018)
The TGFβ pathway stimulates ovarian cancer cell proliferation by increasing IGF1R levels
Elisenda Alsina-Sanchis et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Mechanisms and Targets Involved in Dissemination of Ovarian Cancer
Ulrich H. Weidle et al.
CANCER GENOMICS & PROTEOMICS (2016)
The PDGFRβ-AKT Pathway Contributes to CDDP-Acquired Resistance in Testicular Germ Cell Tumors
M. Juliachs et al.
CLINICAL CANCER RESEARCH (2014)
Mesenchymal Stromal Cells: Inhibiting PDGF Receptors or Depleting Fibronectin Induces Mesodermal Progenitors with Endothelial Potential
S. G. Ball et al.
STEM CELLS (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
A phase II trial of Sunitinib malate in recurrent and refractory ovarian, fallopian tube and peritoneal carcinoma
Susana M. Campos et al.
GYNECOLOGIC ONCOLOGY (2013)
Getting to know ovarian cancer ascites: opportunities for targeted therapy-based translational research
Nuzhat Ahmed et al.
FRONTIERS IN ONCOLOGY (2013)
Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research
Emma Kipps et al.
NATURE REVIEWS CANCER (2013)
Cell-cell and cell-matrix dynamics in intraperitoneal cancer metastasis
Katharine L. Sodek et al.
CANCER AND METASTASIS REVIEWS (2012)
A phase II evaluation of lapatinib in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A gynecologic oncology group study
Agustin A. Garcia et al.
GYNECOLOGIC ONCOLOGY (2012)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
A phase II study of sunitinib in patients with recurrent epithelial ovarian and primary peritoneal carcinoma: an NCIC Clinical Trials Group Study
J. J. Biagi et al.
ANNALS OF ONCOLOGY (2011)
Molecular signatures database (MSigDB) 3.0
Arthur Liberzon et al.
BIOINFORMATICS (2011)
The genesis and evolution of high-grade serous ovarian cancer
David D. L. Bowtell
NATURE REVIEWS CANCER (2010)
Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells
Nathan J. Bowen et al.
BMC MEDICAL GENOMICS (2009)
Multicellular spheroids in ovarian cancer metastases: Biology and pathology
Kristy Shield et al.
GYNECOLOGIC ONCOLOGY (2009)
The biology of ovarian cancer: new opportunities for translation
Robert C. Bast et al.
NATURE REVIEWS CANCER (2009)
Pattern and prognostic factors in patients with malignant ascites: a retrospective study
A. A. Ayantunde et al.
ANNALS OF ONCOLOGY (2007)
A phase II and pharmacodynamic study of gefitinib in patients with refractory or recurrent epithelial ovarian cancer
Edwin M. Posadas et al.
CANCER (2007)
Mechanisms of transcoelomic metastasis in ovarian cancer
David S. P. Tan et al.
LANCET ONCOLOGY (2006)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Phase II study of gefitinib in patients with relapsed or persistent ovarian or primary peritoneal carcinoma and evaluation of epidermal growth factor receptor mutations and immunohistochemical expression: a Gynecologic oncology group study
RJ Schilder et al.
CLINICAL CANCER RESEARCH (2005)
Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-β in ovarian serous carcinoma and normal ovarian surface epithelium
RE Schmandt et al.
CANCER (2003)
Ovarian cancer: Strategies for overcoming resistance to chemotherapy
R Agarwal et al.
NATURE REVIEWS CANCER (2003)
Share Paper
